Heavyweight new drug approved. Merck's stock price reaches a new historical high, from Wall Street to Lujiazui
阿豆学长长ov
发表于 2024-3-29 12:07:57
258
0
0
The heavyweight new drug has been approved, and Merck's stock price has reached a new historical high. Winrevair expects annual sales of $5 billion for patients with pulmonary arterial hypertension (PAH).
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Has the release of heavyweight data in the United States stabilized interest rate cuts? What do you think of Wall Street?
- Global highlights for next week: Super central bank hits hard, Federal Reserve's favorite inflation indicator released
- One week outlook | Led by the Federal Reserve, the last "central bank super week" of the year is coming with a heavy blow; China's November economic data and important inflation data from the United States are about to be released
- Wall Street is guessing that the Federal Reserve won't be able to lower interest rates many times next year? There are still traders who don't buy it!
- Heavy night! The Federal Reserve cuts interest rates by 25 basis points, causing the US dollar to soar instantly! The latest interpretation has arrived
- Worries may become a reality! Wall Street frenzy hit hard, can the US stock market continue its strong performance next year
- Will there only be two interest rate cuts next year? Wall Street: The Federal Reserve may change its mind, and the current sell-off is a good opportunity to buy at the bottom!
- Major changes in the Federal Reserve! The prospect of interest rate cuts changes, leading to heated discussions on Wall Street
- Will the Federal Reserve return to the path of raising interest rates next year? Top Wall Street Economist: 40% Probability
- Global highlights next week: Wall Street cautious over Chinese New Year, key to Trump's long short relationship with Federal Reserve
